- Home
- BANL vs CRIS Comparison
BANL vs CRIS Comparison
Compare BANL & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BANL
- CRIS
- Stock Information
- Founded
- BANL 2015
- CRIS 2000
- Country
- BANL Malaysia
- CRIS United States
- Employees
- BANL N/A
- CRIS N/A
- Industry
- BANL Oil Refining/Marketing
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BANL Energy
- CRIS Health Care
- Exchange
- BANL Nasdaq
- CRIS Nasdaq
- Market Cap
- BANL 31.5M
- CRIS 32.8M
- IPO Year
- BANL 2023
- CRIS 2000
- Fundamental
- Price
- BANL $1.12
- CRIS $1.19
- Analyst Decision
- BANL
- CRIS Strong Buy
- Analyst Count
- BANL 0
- CRIS 3
- Target Price
- BANL N/A
- CRIS $21.00
- AVG Volume (30 Days)
- BANL 45.7K
- CRIS 85.0K
- Earning Date
- BANL 04-16-2025
- CRIS 05-06-2025
- Dividend Yield
- BANL N/A
- CRIS N/A
- EPS Growth
- BANL N/A
- CRIS N/A
- EPS
- BANL N/A
- CRIS N/A
- Revenue
- BANL $521,173,543.00
- CRIS $10,908,000.00
- Revenue This Year
- BANL N/A
- CRIS N/A
- Revenue Next Year
- BANL N/A
- CRIS $27.88
- P/E Ratio
- BANL N/A
- CRIS N/A
- Revenue Growth
- BANL 24.34
- CRIS 8.83
- 52 Week Low
- BANL $0.55
- CRIS $1.02
- 52 Week High
- BANL $1.35
- CRIS $16.99
- Technical
- Relative Strength Index (RSI)
- BANL 57.16
- CRIS 15.51
- Support Level
- BANL $0.80
- CRIS $1.02
- Resistance Level
- BANL $1.17
- CRIS $1.30
- Average True Range (ATR)
- BANL 0.10
- CRIS 0.24
- MACD
- BANL 0.01
- CRIS -0.09
- Stochastic Oscillator
- BANL 86.04
- CRIS 8.82
About BANL CBL International Limited
CBL International Ltd is a company that provides a complete range of marine fuel logistics services. It sources the highest quality marine fuel from its trusted suppliers and ensures timely delivery to its customers. The company's expertise lies in providing a seamless and efficient one-stop solution for vessel refueling needs, making it a reliable partner for shipping companies. CBL International Ltd has a strong presence in China, Hong Kong, and Malaysia.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.